Advertisement

Topics

Blue Chip Partners Inc. Acquires 17 Shares of Bristol-Myers Squibb Company

19:39 EDT 5 Aug 2017 | Topix

Blue Chip Partners Inc. raised its position in Bristol-Myers Squibb Company by 0.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,141 shares of the biopharmaceutical company's stock after buying an additional 17 shares during the period.

Original Article: Blue Chip Partners Inc. Acquires 17 Shares of Bristol-Myers Squibb Company

NEXT ARTICLE

More From BioPortfolio on "Blue Chip Partners Inc. Acquires 17 Shares of Bristol-Myers Squibb Company"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...